NFS-60 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | NFS-60 is a murine myeloblastic cell line established from leukemic cells obtained after infection of (NFS x DBA/2) F1 adult mice with Cas Br-M murine leukemia virus. NFS-60 cells are dependent on IL3 for growth and maintenance of viability in vitro. These cells are used to assay murine and human G-CSF. This bipotential murine hematopoietic cell line is responsive to IL-3, GM-CSF, G-CSF, and erythropoietin. |
|---|---|
| Organism | Mouse |
| Tissue | Blood |
| Disease | Leukemia |
| Synonyms | M-NFS-60, NFS 60, NFS60 |
Characteristics
| Breed/Subspecies | NFS x DBA/2 |
|---|---|
| Cell type | Lymphoblast |
| Growth properties | Suspension |
Regulatory Data
| Citation | NFS-60 (Cytion catalog number 400301) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_3543 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS, 1 ng/mL IL-3 |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Seeding density | Start cultures at 5 x 104 viable cells/ml. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 400301-814SF | Certificate of Analysis | 23. May. 2025 | 400301 |